Who has invested in Gmax Biopharm?

China Merchants Group, Tigermed, Parkland Medtech Limited, Cowin Capital, Ziyao Fund are named among the investors backing Gmax Biopharm.

Gmax Biopharm Funding: $78M Raised, Series C (2021)

Gmax Biopharm funding overview

Gmax Biopharm is based in Hangzhou, China. Gmax Biopharm has raised $78M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in March 2021. The round record for Gmax Biopharm runs through 2021; nothing later has been disclosed. Investors on record include China Merchants Group, Tigermed, Parkland Medtech Limited, Cowin Capital, Ziyao Fund. 5 distinct backers are named across the disclosed rounds.

Gmax Biopharm at a glance

Total raised: $78M
Latest round: Series C
Latest round date: March 2021
Headquarters: Hangzhou, China
Notable investors: China Merchants Group, Tigermed, Parkland Medtech Limited, Cowin Capital, Ziyao Fund

Frequently asked about Gmax Biopharm funding

How much has Gmax Biopharm raised?: Gmax Biopharm has raised $78M in total disclosed funding across the rounds on record.
Who has invested in Gmax Biopharm?: China Merchants Group, Tigermed, Parkland Medtech Limited, Cowin Capital, Ziyao Fund are named among the investors backing Gmax Biopharm.
What was the latest Gmax Biopharm funding round?: The most recent disclosed round is a Series C, announced in March 2021.
Where is Gmax Biopharm based?: Gmax Biopharm is based in Hangzhou, China.
When did Gmax Biopharm last raise?: The last disclosed Gmax Biopharm round closed in March 2021 at Series C.

Round data for Gmax Biopharm is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Hangzhou and backer lists below.

Gmax Biopharm Funding: $78M Raised, Series C (2021)

Gmax Biopharm funding overview

Gmax Biopharm at a glance

Frequently asked about Gmax Biopharm funding

Companies related to Gmax Biopharm (21)

Browse related funding lists (4)